CAS No.: 402567-16-2
Firategrast/非拉司特 Catalog No. CSN17362
Synonyms: SB 683699;T-0047;非拉司特
Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT00395317 Multiple Sclerosis Phase 2 Completed - - NCT00469378 Multiple Sclerosis Phase 2 Completed - Belgium ... more >> GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Bruxelles, Belgium, 1200 Czech Republic GSK Investigational Site Olomouc, Czech Republic, 775 20 GSK Investigational Site Praha 2, Czech Republic, 120 00 Denmark GSK Investigational Site Glostrup, Denmark, DK-2600 GSK Investigational Site Koebenhavn Ø, Denmark, 2100 Norway GSK Investigational Site Lørenskog, Norway, 1478 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Stockholm, Sweden, SE-171 76 GSK Investigational Site Umeå, Sweden, SE-901 85 Collapse << NCT01416363 Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << Phase 1 Completed - Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Collapse << - 更多
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 402567-16-2 | 储存条件 |
|
|
| 分子式 | C27H27F2NO6 | 运输 | 蓝冰 | |
| 分子量 | 499.50 | 别名 | SB 683699;T-0047;非拉司特 |
